Want to see JP:3544 full AI Analyst Report?
3544 Stock Chart & Stats
¥819.00
¥4.00(0.49%)
At close: 4:00 PM EST
¥819.00
¥4.00(0.49%)
Day’s Range― - ―
52-Week Range¥791.00 - ¥1,328.00
Previous CloseN/A
Volume32.00K
Average Volume (3M)29.60K
Market Cap
¥16.87B
Enterprise Value¥25.06K
Total Cash (Recent Filing)¥1.48B
Total Debt (Recent Filing)¥15.23B
Price to Earnings (P/E)39.9
Beta0.07
Next Earnings
Sep 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.98%
Share Statistics
EPS (TTM)31.50
Shares Outstanding14,236,564
10 Day Avg. Volume15,720
30 Day Avg. Volume29,603
Financial Highlights & Ratios
PEG Ratio-0.60
Price to Book (P/B)1.12
Price to Sales (P/S)0.11
P/FCF Ratio23.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Stable/modest Revenue GrowthConsistent modest revenue growth (2024–26: +9.2%, +4.9%, +0.6% per the summary) indicates resilient consumer demand for its drugstore and health & beauty retailing. Durable top-line stability supports scale economics, steadier purchasing, and underpins long-term cash generation and reinvestment capacity.
Improving Leverage TrendMeasured reduction in leverage strengthens financial flexibility. Moving from ~2.1x to ~1.5x D/E reduces interest burden and default risk, improving the company’s ability to fund store investment, working capital and selective M&A without relying solely on external equity, which aids resilience through cycles.
Operations Are Cash-generativePositive operating cash flow and positive free cash flow demonstrate the business can convert sales into cash. This ongoing cash generation, even if smaller than prior years, provides a foundation to fund maintenance capex, inventory needs and gradual deleveraging, supporting operational continuity over the medium term.
Bears Say
Very Thin, Volatile ProfitabilityProfitability is razor-thin and fell materially in 2026. Margins near 0.4% provide almost no cushion against cost inflation, supplier or payroll pressures. Such low and volatile profit rates constrain ability to build reserves, invest in growth initiatives, or sustain dividends when sales slow.
Elevated Leverage Relative To MarginsEven with recent improvement, elevated leverage paired with low EBIT margins (~1.5%) heightens financial risk. Debt obligations consume a larger share of earnings in downturns, limiting flexibility for strategic spending and increasing the chance that management must cut investments or sell assets to protect liquidity.
Inconsistent Cash Conversion And Falling FCFFree cash flow has declined sharply versus prior years and covered only ~20% of net income in 2026. This inconsistent cash conversion undermines predictability for capital expenditures, debt paydown and shareholder returns, forcing management to prioritize near-term liquidity over long-term strategic investments.
SATUDORA HOLDINGS CO., LTD. News
3544 FAQ
What was SATUDORA HOLDINGS CO., LTD.’s price range in the past 12 months?
SATUDORA HOLDINGS CO., LTD. lowest stock price was ¥791.00 and its highest was ¥1328.00 in the past 12 months.
What is SATUDORA HOLDINGS CO., LTD.’s market cap?
SATUDORA HOLDINGS CO., LTD.’s market cap is ¥16.87B.
When is SATUDORA HOLDINGS CO., LTD.’s upcoming earnings report date?
SATUDORA HOLDINGS CO., LTD.’s upcoming earnings report date is Sep 18, 2026 which is in 59 days.
How were SATUDORA HOLDINGS CO., LTD.’s earnings last quarter?
SATUDORA HOLDINGS CO., LTD. released its earnings results on Jun 19, 2026. The company reported -¥3.7 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is SATUDORA HOLDINGS CO., LTD. overvalued?
According to Wall Street analysts SATUDORA HOLDINGS CO., LTD.’s price is currently Overvalued.
Does SATUDORA HOLDINGS CO., LTD. pay dividends?
SATUDORA HOLDINGS CO., LTD. pays a Annually dividend of ¥12 which represents an annual dividend yield of 0.98%. See more information on SATUDORA HOLDINGS CO., LTD. dividends here
What is SATUDORA HOLDINGS CO., LTD.’s EPS estimate?
SATUDORA HOLDINGS CO., LTD.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SATUDORA HOLDINGS CO., LTD. have?
SATUDORA HOLDINGS CO., LTD. has 14,236,564 shares outstanding.
What happened to SATUDORA HOLDINGS CO., LTD.’s price movement after its last earnings report?
SATUDORA HOLDINGS CO., LTD. reported an EPS of -¥3.7 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.867%.
Which hedge fund is a major shareholder of SATUDORA HOLDINGS CO., LTD.?
Currently, no hedge funds are holding shares in JP:3544
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SATUDORA HOLDINGS CO., LTD.
Satudora Holdings Co., Ltd. is a Japanese enterprise primarily focused on operating drugstores and dispensing pharmacies. Its business operations are structured into two main divisions: Retail Business and IT Solution Business. Beyond its core retail activities, the company also oversees a variety of regional marketing initiatives. These include the EZOCA payment service, programming education centers for elementary and junior high school students, and the distribution of Point-of-Sale (POS) applications. Additionally, Satudora Holdings participates in wholesale trade, product development, and the energy sector. As of May 30, 2022, the company maintained a network comprising 175 drugstores, 14 other drug retail locations, 10 specialized dispensing pharmacies, and 2 different types of stores. Founded in 1972, Satudora Holdings Co., Ltd. maintains its headquarters in Sapporo, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―




